Levels of cysteinyl-leukotrienes in exhaled breath condensate are not due to saliva contamination

Clinical Respiratory Journal

Volumn 4, Issue 2, 2010, Pages 83-88

  Tufvesson, Ellen ^a   Van Weele, Linda Jacqueline ^a   Ekedahl, Henrik ^a   Bjermer, Leif ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Asthma; Cysteinyl leukotrienes; Exhaled breath condensate; Saliva; Sputum; amylase

Indexed keywords

AMYLASE; CORTICOSTEROID; PEPTIDOLEUKOTRIENE; LEUKOTRIENE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTAMINATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROBABILITY; REFERENCE VALUE; RESPIRATORY TRACT PARAMETERS; SALIVA; SALIVA CONTAMINATION; SPUTUM; BREATH ANALYSIS; CASE CONTROL STUDY; CHEMISTRY; FEASIBILITY STUDY; MIDDLE AGED; YOUNG ADULT;

ADULT; ALPHA-AMYLASES; ASTHMA; BREATH TESTS; CASE-CONTROL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; SALIVA; SPUTUM; YOUNG ADULT;

EID: 77949881057     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/j.1752-699X.2009.00151.x     Document Type: Article

References (29)

1. Kharitonov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med Wkly. 2004 134 (13-14 175 192.
2. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy. 2008 38 (4 557 565.
3. Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci. 2002 23 (5 232 237.
4. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax. 2003 58 (6 505 509.
5. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med. 2002 166 (10 1345 1349.
6. Mondino C, Ciabattoni G, Koch P, Pistelli R, Trove A, Barnes PJ, Montuschi P. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol. 2004 114 (4 761 767.
7. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol. 2006 118 (2 347 353.
8. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med. 2002 166 (3 301 306.
9. Cap P, Chladek J, Pehal F, Maly M, Petru V, Barnes PJ, Montuschi P. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax. 2004 59 (6 465 470.
10. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol. 2002 109 (4 615 620.
11. Zanconato S, Carraro S, Corradi M, Alinovi R, Pasquale MF, Piacentini G, Zacchelo F, Baraldi E. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol. 2004 113 (2 257 263.
12. Carraro S, Corradi M, Zanconato S, Alinovi R, Pasquale MF, Zacchello F, Baraldi E. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2005 115 (4 764 770.
13. Samitas K, Chorianopoulos D, Vittorakis S, Zervas E, Economidou E, Papatheodorou G, Loukides S, Gaga M. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med. 2009 103 (5 750 756.
14. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis. 2007 1 (1 5 23.
15. Hunt J. Exhaled breath condensate: an overview. Immunol Allergy Clin North Am. 2007 27 (4 587 596.
16. Griese M, Noss J, von BC. Protein pattern of exhaled breath condensate and saliva. Proteomics. 2002 2 (6 690 696.
17. Hoffmann HJ, Tabaksblat LM, Enghild JJ, Dahl R. Human skin keratins are the major proteins in exhaled breath condensate. Eur Respir J. 2008 31 (2 380 384.
18. Effros RM, Hoagland KW, Bosbous M, Castillo D, Foss B, Dunning M, Gare M, Lin W, Sun F. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med. 2002 165 (5 663 669.
19. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar VG, Herjavecz I, Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J. 2002 20 (6 1393 1398.
20. de Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, Motta A, Sofia M. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J. 2008 32 (5 1175 1183.
21. Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005 26 (3 523 548.
22. Gaber F, Acevedo F, Delin I, Sundblad BM, Palmberg L, Larsson K, Kumlin M, Dahlen SE. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J. 2006 28 (6 1229 1235.
23. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2005. Available from URL: http://www.ginasthma.com (accessed 2008).
24. Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med. 2006 100 (1 34 8.
25. Tufvesson E, Aronsson D, Bjermer L. Cysteinyl-leukotriene levels in sputum differentiate asthma from rhinitis patients with or without bronchial hyperresponsiveness. Clin Exp Allergy. 2007 37 (7 1067 1073.
26. Sampson AP, Pizzichini E, Bisgaard H. Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation. J Allergy Clin Immunol. 2003 111 (1 Suppl S49 S59.
27. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med. 2000 162 (3 Pt 1 878 882.
28. Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med. 1999 160 (6 1905 1909.
29. Gaber F, Daham K, Higashi A, Higashi N, Gulich A, Delin I, James A, Skedinger M, Gyllfors P, Nord M, Dahlen SE, Kumlin M, Dahlen B. Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma. Thorax. 2008 63 (12 1076 1082.